Skip to main content
Clinical Trials/NCT04233125
NCT04233125CompletedPhase 1

A Randomized Controlled Trial of Core Decompression With or Without Cement Packing for Osteonecrosis of the Femoral Head - Long Term Results

University of Minnesota0 sites37 target enrollmentStarted: January 1, 1997Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
37
Primary Endpoint
Progression Free Survival (PFS)

Study Overview

Brief Summary

Osteonecrosis of the femoral head (ONFH) is difficult to treat as collapse frequently occurs after core decompression (CD). This may be due to the failure to provide structural support during revascularization and healing. Reports of polymethylmethacrylate (PMMA) packing of the femoral head after CD for ONFH have noted favorable results. This study was undertaken to determine whether the addition of PMMA packing to CD provides any benefit to progression-free survival (PFS) and conversion to total hip arthroplasty-free survival (CFS). Secondary objectives were to assess for differences in functional outcomes and predictive factors for progression of the disease.

Detailed Description

A prospective randomized controlled trial comparing the results of CD vs. CD + PMMA packing in pre-collapse ONFH was set up.

Consecutive symptomatic patients aged >14 years with Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging were enrolled in this study.

Exclusion criteria were pre-existing collapse, sub-chondral fracture or degenerative changes of the hip.

After obtaining informed written consent, patients are asked to complete the Harris Hip Score (HHS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and a health status questionnaire Short Form-36 (SF-36).

The femoral heads enrolled into the study are randomized using a computer-generated card draw system to one of following: core decompression (CD) or core decompression with PMMA cement packing (CD + PMMA).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Association Research Circulation Osseous (ARCO) Stage I and II ONFH diagnosed using MRI and radiographic imaging

Exclusion Criteria

  • •pre-existing collapse, subchondral fracture or degenerative changes of the hip

Arms & Interventions

Core Decompression (CD) Only

Active Comparator

Participants in this group receive standard care

Intervention: Core Decompression (Procedure)

Added Polymethylmethacrylate (PMMA)

Experimental

Participants in this group receive standard care with an additional treatment

Intervention: Core Decompression (Procedure)

Added Polymethylmethacrylate (PMMA)

Experimental

Participants in this group receive standard care with an additional treatment

Intervention: PMMA augmentation (Procedure)

Outcomes

Primary Outcomes

Progression Free Survival (PFS)

Time Frame: 5 years

Progression Free Survival (PFS) is defined as the length of time (reported in months) following surgery that participants have no signs of radiographic progression of femoral head osteonecrosis. Radiographic progression is defined as any degree of flattening or loss of spherical contour of the femoral head as detected on the radiographs or MRI. Appearance of a subchondral fracture (crescent sign) on radiographs or MRI was also considered a sign of progression.

Secondary Outcomes

  • Change in Harris Hip Score (HHS)(baseline, 2 years post surgery)
  • Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)(baseline, 2 years post surgery)
  • Conversion Free Survival (CFS)(5 years)
  • Change in Short Form-36 (SF-36)(baseline, 2 years post surgery)
  • Mean Harris Hip Score (HHS)(baseline, 2 years post surgery, 5 years post surgery)
  • Mean Short Form-36 (SF-36)(baseline, 2 years post surgery, 5 years post surgery)
  • Mean Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)(baseline, 2 years post surgery, 5 years post surgery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials

Core Decompression With or Without Cement... | Clinical Trial